Atlas Trials

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults

Clinical trial NCT01854528 · COMPLETED

Trial details

NCT number
NCT01854528
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Hepatitis C Infection
Start date
2013-06-01
Primary completion
2014-11-01
Enrollment
148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.